Home/Pipeline/ClotHound™ Thrombectomy System

ClotHound™ Thrombectomy System

Deep Vein Thrombosis (DVT)

Pre-clinicalActive

Key Facts

Indication
Deep Vein Thrombosis (DVT)
Phase
Pre-clinical
Status
Active
Company

About Retriever Medical

Retriever Medical is a pre-revenue, clinical-stage medical device company targeting the venous thrombectomy market with its ClotHound™ system. The device is engineered to mechanically engage and remove acute, sub-acute, and chronic wall-adherent thrombus while providing distal embolic protection, a key differentiator. The company is advancing the system through preclinical validation with a regulatory pathway targeting 510(k) clearance for DVT, and the platform has potential future applications in pulmonary embolism and complex venous thrombosis. Founded in 2016, the company is headquartered in San Jose, California.

View full company profile

Therapeutic Areas

Other Deep Vein Thrombosis (DVT) Drugs

DrugCompanyPhase
ClotTriever SystemInari MedicalCommercial